Osimertinib mesylate

Osimertinib mesylate
Product Description

for the treatment of non-small cell lung cancer (NSCLC) caused by specific gene mutations

Shandong Shengyuan Pharmaceutical Co., L

  • Country/Region:
    China
  • On CPHI since:
    2025
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Generics/Biosimilars Manufacturer
Pharmaceutical company
Wholesale/Retail
Primary activities
API Producer
Pharmaceutical Company (generic finished products)
Specifications
  • CAS Registry Number
    1421373-66-1
  • Supplied from
    China
  • Measured In
    kilogram

Shandong Shengyuan Pharmaceutical Co., L

  • Country/Region:
    China
  • On CPHI since:
    2025
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Generics/Biosimilars Manufacturer
Pharmaceutical company
Wholesale/Retail
Primary activities
API Producer
Pharmaceutical Company (generic finished products)

More Products from Shandong Shengyuan Pharmaceutical Co., L (21)